Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Sonata (zaleplon) CIV Capsules, Wyeth-Ayerst NDA 20-859/S2 & S3 5/31/02 6/3/02 Sonata (zaleplon) Capsule, 5 mg & 10 mg, Wyeth-Ayerst NDA 20-859/S1 2/22/01 3/5/01 3/5/01 Sonata (zaleplon) Capsule, Wyeth-Ayerst NDA 20-859 8/13/99 3/21/00 3/21/00 7/3/00 Sonata Indications: short-term treatment of insomnia ZALEPLON Capsule; 10MG SONATA JONES 020859 ZALEPLON Capsule; 5MG SONATA JONES | Zaleplon Capsules, Roxane Labs, Tentative Approval | Zaleplon Capsules, Teva Pharma, Tentative Approval | Zaleplon Capsules, Genpharm, Tentative Approval Check the most up-to-date list of FDA Approvals.                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2009 Betterchem.com